ETR:HNL - Dr Hoenle Stock Price, News, & Analysis

€58.00
-1.20 (-2.03 %)
(As of 06/24/2019 04:00 PM ET)
Today's Range
€57.20
Now: €58.00
€59.50
50-Day Range
€51.10
MA: €55.72
€60.80
52-Week Range
€41.30
Now: €58.00
€89.20
Volume2,367 shs
Average VolumeN/A
Market Capitalization$319.69 million
P/E Ratio17.68
Dividend Yield1.36%
BetaN/A
Dr. Hönle AG operates in the UV market worldwide. It operates through three segments: Equipment & Systems, Glass & Lamps, and Adhesives. The Equipment & Systems segment offers UV equipment and systems, LED-UV units, IR units, inert systems, disinfection systems, solar simulation systems and light fixtures, lighting systems, UV measuring technology products, UV-adhesives, and components and replacement parts. This segment also provides hot air systems, and powder spraying and extraction systems for sheet-fed offset printing; UV dryers for Web printing; UV systems with nitrogen inertisation for rotary printing; and drying systems. Its products are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Glass & Lamps segment offers UV low and medium pressure lamps; infrared emitters; electronic power supplies; UV sensors and measuring technology products; UV measuring devices; and submersible and immersion tube systems, as well as accessories. This segment also provides UV bulbs; and quartz glass tubing and rods for the lamp, automotive, semiconductor, and fiber cable industries. The Adhesives segment offers industrial, UV, medical grade, and conductive adhesives; dosing systems; potting and sealing compounds; and UV curing units. Dr. Hönle AG was founded in 1976 and is headquartered in Gräfelfing, Germany.

Industry, Sector and Symbol

Industry Electronic Components
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone49 89 85608 0

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$122.02 million
Cash Flow€2.71 per share
Book Value€16.01 per share

Profitability

Miscellaneous

Employees638
Market Cap$319.69 million
Next Earnings DateN/A
OptionableNot Optionable

Receive HNL News and Ratings via Email

Sign-up to receive the latest news and ratings for HNL and its competitors with MarketBeat's FREE daily newsletter.

Dr Hoenle (ETR:HNL) Frequently Asked Questions

What is Dr Hoenle's stock symbol?

Dr Hoenle trades on the ETR under the ticker symbol "HNL."

What price target have analysts set for HNL?

1 analysts have issued 1-year target prices for Dr Hoenle's stock. Their predictions range from €82.00 to €82.00. On average, they expect Dr Hoenle's share price to reach €82.00 in the next twelve months. This suggests a possible upside of 41.4% from the stock's current price. View Analyst Price Targets for Dr Hoenle.

What is the consensus analysts' recommendation for Dr Hoenle?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr Hoenle in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dr Hoenle.

Has Dr Hoenle been receiving favorable news coverage?

Media coverage about HNL stock has been trending somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dr Hoenle earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the stock's share price in the next several days. View News Stories for Dr Hoenle.

Who are some of Dr Hoenle's key competitors?

Who are Dr Hoenle's key executives?

Dr Hoenle's management team includes the folowing people:
  • Dr. Norbert Haimerl, CFO, MD, Director of Fin. & HR and Member of Management Board (Age 57)
  • Mr. Heiko Runge, CTO, MD of Sales & Technology and Member of Management Board (Age 55)
  • Peter Weinert, Head of Investor Relations

What is Dr Hoenle's stock price today?

One share of HNL stock can currently be purchased for approximately €58.00.

How big of a company is Dr Hoenle?

Dr Hoenle has a market capitalization of $319.69 million and generates $122.02 million in revenue each year. Dr Hoenle employs 638 workers across the globe.View Additional Information About Dr Hoenle.

What is Dr Hoenle's official website?

The official website for Dr Hoenle is http://www.hoenle.de/.

How can I contact Dr Hoenle?

The company can be reached via phone at 49 89 85608 0.


MarketBeat Community Rating for Dr Hoenle (ETR HNL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  17
MarketBeat's community ratings are surveys of what our community members think about Dr Hoenle and other stocks. Vote "Outperform" if you believe HNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HNL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel